Abstract
Half-life and apparent specific volume of distribution of hexobarbital, sulphadimidine and chloramphenicol were investigated in newborn, 1, 3, 5 and 8 weeks old pigs. Hexobarbital sleeping time and plasma concentration of hexobarbital at recovery were measured in the same age groups. The half-life of hexobarbital and chloramphenicol was long in newborn pigs but decreased fast during the first week after birth. From 1 to 8 weeks after birth the decrease was less pronounced. The half-life of sulphadimidine increased during the first 3 weeks of life, but in 1 and 3 weeks old pigs the amount of N4-acetylated sulphadimidine in plasma at 200 min. after the injection was higher than in the newborn pigs.
The apparent specific volume of distribution of hexobarbital, sulphadimidine and chloramphenicol was changed in different ways from birth to 8 weeks of age.
The hexobarbital sleeping time was very long in the newborn pigs and decreased until 3 weeks of age. The concentration of hexobarbital in plasma at recovery was unchanged from birth to 8 weeks of age.
The concentration of chloramphenicol metabolites in plasma 100 min. after the injection increased very fast during the 8 weeks of observation. The concentration of N4-acetylated sulphadimidine in plasma at 200 min. after the injection increased from birth to 1 week of age, then it decreased.
The data are stressing that the neonatal pig is a convenient model for pharmacokinetic testing of drugs used as pharmacotherapeutics in neonatal life.
Article PDF
Similar content being viewed by others
References
Barnett, H. L. & J. Vesterdal: The physiologie and clinical significance of immaturity of kidney function in young infants. J. Pediat. 1953, 42, 99–119.
Basu, T. K., J. W. T. Dickerson & D. V. W. Parke: Effect of development on the activity of microsomal drug-metabolizing enzymes in rat liver. Biochem. J. 1971, 124, 19–24.
Bessman, S. P. & S. Stevens: A colorimetric method for the determination of Chloromycetin in serum and plasma. J. Lab. clin. Med. 1950, 35, 129–134.
Bratton, A. C. & E. K. Marshall: A new coupling component for sulfonamide determination. J. biol. Chem. 1939, 128, 537–550.
Brooks, C. C. & J. W. Davis: Changes in the perinatal pig. J. Animal Sei. 1969, 29, 325–329.
Butler, T. C.: The distribution of drugs. In Fundamentals of Drug Metabolism and Drug Disposition, ed. B. N. LaDu, H. G. Mandel & E. L. Way. The Williams & Wilkins Company, Baltimore 1971, pp. 44–62.
Catz, C. & S. J. Yaffe: Strain and age variations in hexobarbital response. J. Pharmacol, exp. Ther. 1967, 155, 152–156.
Chignell, C. F., E. S. Vesell, D. K. Starkweather & C. M. Berlin: The binding of sulfaphenazole to fetal, neonatal, and adult human plasma albumin. Clin. Pharmacol. Ther. 1971, 12, 897–901.
Cooper, J. R. & B. B. Brodie: The enzymatic metabolism of hexobarbital (evipan). J. Pharmacol, exp. Ther. 1955, 114, 409–417.
Davis, L. E., C. A. Neff & J. D. Baggot: Comparative pharmacokinetics in domesticated animals. Nat. Conf. Res., Animals in Med., Washington, D.C., Jan. 1972.
Davis, L. E., B. A. Westfall & C. R. Short: Biotransformation and pharmacokinetics of salicylate in newborn animals. Amer. J. vet. Res. 1973, 34, 1105–1108.
Donald, H. P. & J. Raventôs: Influence of age and weight of pigs on response to sodium evipan. J. Pharmacol, exp. Ther. 1939, 65, 383–388.
Done, A. K.: Perinatal pharmacology. Ann. Rev. Pharmacol. 1966, 6, 189–208.
Ehrnebo, M., S. Agurell, B. Jailing & L. O. Boréus: Age differences in drug binding by plasma proteins: Studies on human foetuses, neonates and adults. Europ. J. clin. Pharmacol. 1971, 3, 189–193.
Fichter, E. G. & J. A. Curtis: Sulfonamide administration in newborn and premature infants. Pediatrics 1956, 18, 50–59.
Fouts, J. R.: Hepatic microsomal drug metabolism in the perinatal period. In Diagnosis and Treatment of Fetal Disorders, ed. K. Adamson. Springer Verlag, N.Y. 1968, pp. 291–304.
Fouts, J. R.: Microsomal mixed-function oxidases in the fetal and newborn rabbit. In Fetal Pharmacology, ed. L. Boréus. Raven Press, New York 1973, pp. 305–320.
Fouts, J. R. & R. H. Adamson: Drug metabolism in the newborn rabbit. Science 1959, 129, 897–898.
Ganshorn, A. & H. Kurz: Unterschiede zwischen der Proteinbindung Neugeborener und Erwachsener und ihre Bedeutung für die pharmakologische Wirkung. (Differences between protein binding in newborns and adults and influence on pharmacologic action). Naunyn-Schmiedeberg’s Arch. Pharmacol. 1968, 260, 117–118.
Gladtke, E. & H. Rind: Sulfonamide bei unreifen und reifen Trimenonkindern. 3rd Int. Congr. Chemotherapy, Stuttgart 1965, pp. 656–659.
Glazko, A. J.: Identification of chloramphenicol metabolites and some factors affecting metabolic disposition. In Antimicrobial Agents and Chemotherapy, ed. G. L. Hobby, American Society for Mi, Crobiology 1967.
Glazko, A. J., L. M. Wolf, IV. A. Dill & A. C. Bratton: Biochemical studies on chloramphenicol (Chloromycetin). II. Tissue distribution and excretion studies. J. Pharmacol, exp. Ther. 1949, 96, 445–459.
Glazko, A. J., TV. A. Dill & L. M. Wolf: Observation on the metabolic disposition of chloramphenicol (Chloromycetin) in the rat. J. Pharmacol, exp. Ther. 1952, 104, 452–458.
Henderson, P. T.: Metabolism of drugs in rat liver during the perinatal period. Biochem. Pharmacol. 1971, 20, 1225–1232.
Hörster, M. & J. E. Lewy: Filtration fraction and extraction of PAH during neonatal period in the rat. Amer. J. Physiol. 1970, 219, 1061–1065.
Hughes, D. TV. O. & L. K. Diamond: Chloramphenicol in blood: Simple chemical estimations in patients receiving multiple antibiotics. Science 1964, 144, 296–297.
Ingall, D. & J. O. Klein: Levels of penicillins in serum of newborn infants. 5th Int. Congr. Chemotherapy 1967, 1, 407–410.
Jondorf, TV. R., R. T. Maickel & B. B. Brodie: Inability of newborn mice and guinea pigs to metabolize drugs. Biochem. Pharmacol. 1958, 1, 352–354.
Kakemi, K., T. Arita & S. Ohashi: Absorption and excretion of drugs. IV. Determination of chloramphenicol in blood. Yakugaku Zas-shi. (J. Pharm. Soc. Jap.) 1962, 82, 342–345
Kemp, T.: Statistik for medicinere. (Statistics for physicians). Munks- gaard, Copenhagen 1955.
Klaassen, C. D.: Immaturity of the newborn rat’s hepatic excretory function for ouabain. J. Pharmacol, exp. Ther. 1972, 183, 520–526.
Krauer, B., P. Spring & L. Dettli: Zur Pharmakokinetik der Sulfonamide im ersten Lebensjahr. (Pharmacokinetics of sulphonamides in the first year of life). Pharmacol. Clin. 1968, 1, 47–53.
Manners, M. J. & M. R. McCrea: Changes in the chemical composition of sow-reared piglets during the 1st month of life. Brit. J. Nutr. 1963, 17, 495–513.
Mirkin, B. L.: Developmental pharmacology. Ann. Rev. Pharmacol. 1970, 10, 255–271.
Nishimura, T.: Chloramphenicol in the newborn and premature infants — Absorption and excretion of chloramphenicol. 5th Int. Congr. Chemotherapy 1967, 1, 401–405.
Nyhan, W. L.: Toxicity of drugs in the neonatal period. J. Pediat. 1961, 59, 1–20.
Pruitt, A. W. & P. G. Dayton: A comparison of the binding of drugs to adult and cord plasma. Europ. J. clin. Pharmacol. 1971, 4, 59–62.
Bane, A., M. Berggren, S. Yaffe & J. L. E. Ericsson: Oxidative drug metabolism in the perinatal rabbit liver and placenta. A biochemical and morphologic study. Xenobiotica 1973, 3, 37–48.
Pasmussen, Folke: Personal communication, 1973.
Schulz, B.: Distribution and elimination of trimethoprim in pregnant and newborn rats. Naunyn-Schmiedeberg’s Arch. Pharmacol. 1972, 272, 369–377.
Sereni, F., L. Perletti, N. Manfredi & A. Marini: Tissue distribution and urinary excretion of a tetracycline derivative in newborn and old infants. J. Pediat. 1965, 67, 299–305.
Sereni, F., L. Perletti, E. Marubini & G. Mars: Pharmacokinetic studies with a long-acting sulfonamide in subjects of different ages. Pediat. Res. 1968, 2, 29–37.
Sheng, H. & B. A. Huggins: Growth of the beagle: Changes in the body fluid compartment. Proc. Soc. exp. Biol. (N. Y.) 1972, 139, 330–335.
Short, C. B.: Drug metabolism in newborn swine. Diss. Abstr. Int. 1969, 30 B, 1826.
Short, C. B. & L. E. Davis: Perinatal development of drug-metabolizing enzyme activity in swine. J. Pharmacol, exp. Ther. 1970, 174, 185–196.
Short, C. B. & B. D. Stith: Perinatal development of hepatic microsomal mixed function oxidase activity in swine. Biochem. Pharmacol. 1973, 22, 1309–1319.
Short, C. B. & M. E. Tumbleson: Binding of drugs to plasma proteins of swine during the perinatal period. Toxicol, appl. Pharmacol. 1973, 24, 612–624.
Simon, C., M. Bekesch & V. Malerczyk: Zur Pharmakokinetik von Penicillin V im Kindersalter (insbesondere bei Neugeborenen). (Pharmacokinetics of penicillin V in childhood (especially in newborns)). Med. Welt (Stuttg.) 1972, 23, 1717–1721.
Svendsen, J., M. B. Wilson & E. Eivert: Serum protein levels in pigs from birth to maturity and in young pigs with and without enteric colibacillosis. Acta vet. scand. 1972, 13, 528–538.
Yaffe, S. J.: Some aspects of perinatal pharmacology. Ann. Rev. Med. 1966, 17, 213–234.
Acknowledgements
The author wishes to thank mrs. Lis Bærendsen and mr. Ernst Eriksen for skilful technical assistance during the work.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sυendsen, O. Pharmacokinetics of Hexobarbital, Sulphadimidine and Chloramphenicol in Neonatal and Young Pigs. Acta Vet Scand 17, 1–14 (1976). https://doi.org/10.1186/BF03547938
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1186/BF03547938